Literature DB >> 2759126

Gastrointestinal scintiscanning: dosimetry.

J L Madsen1, O W Krogsgaard.   

Abstract

Calculations of the dosimetry associated with orally administered 99mTc labeled cellulose fibres and 111In labeled plastic particles were performed for adult standard man using MIRD methodology. The applied gastrointestinal transit parameters of these radiopharmaceuticals probably reflect the ranges of these parameters, regarding nondigestible components used for gastrointestinal transit studies. However, the critical organ for both radiopharmaceuticals was the large intestine.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2759126     DOI： 10.1007/BF00257544

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  6 in total

Review 1.  A review of the physiology of the gastrointestinal tract in relation to radiation doses from radioactive materials.

Authors:  I S Eve
Journal:  Health Phys       Date:  1966-02       Impact factor: 1.316

2.  Techniques and errors in scintigraphic measurements of gastric emptying.

Authors:  P Tothill; G P McLoughlin; R C Heading
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

3.  Size of liver particles emptied from the human stomach.

Authors:  J H Meyer; H Ohashi; D Jehn; J B Thomson
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

4.  Gastrointestinal transit of technetium-99m-labeled cellulose fiber and indium-111-labeled plastic particles.

Authors:  J L Madsen; M Jensen
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

5.  Gastroesophageal (GE) scintiscanning to detect and quantitate GE reflux.

Authors:  R S Fisher; L S Malmud; G S Roberts; I F Lobis
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  Radionuclide transit studies in the detection of oesophageal dysmotility.

Authors:  J N Blackwell; W J Hannan; R D Adam; R C Heading
Journal:  Gut       Date:  1983-05       Impact factor: 23.059
  6 in total
  3 in total

1.  In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.

Authors:  Yasuhiro Tsume; Peter Langguth; Alfredo Garcia-Arieta; Gordon L Amidon
Journal:  Biopharm Drug Dispos       Date:  2012-08-21       Impact factor: 1.627

2.  The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.

Authors:  Yasuhiro Tsume; Deanna M Mudie; Peter Langguth; Greg E Amidon; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2014-01-28       Impact factor: 4.384

3.  Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.

Authors:  Min Li; Xinwen Zhang; Di Wu; Om Anand; Hansong Chen; Kimberly Raines; Lawrence Yu
Journal:  AAPS J       Date:  2021-10-26       Impact factor: 4.009
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.